癌症放射治療的增敏劑

Yu-Sun Chang; Ngan-Ming Tsang; SHUCHEN LIU

癌症放射治療的增敏劑

Translated title of the contribution: SENSITIZER FOR CANCER RADIOTHERAPY

Yu-Sun Chang (Inventor), Ngan-Ming Tsang (Inventor), SHUCHEN LIU (Inventor)

Research output: Patent

Abstract

The invention is related to use of a leukemia inhibitory factor inhibitor, and the use is for the manufacture of a sensitizer for cancer radiotherapy.The invention is also related to use of a leukemia inhibitory factor receptor inhibitor, and the use is for the manufacture of a sensitizer for cancer radiotherapy.

Translated title of the contribution	SENSITIZER FOR CANCER RADIOTHERAPY
Original language	Chinese (Traditional)
IPC	A61K 45/08(2006.01); A61P 35/00(2006.01)
State	Published - 16 05 2015

Bibliographical note

公開公告號: 2.01517918E8
Announcement ID: 2.01517918E8

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{507a3c5580c144908b2c77b0f79f5be6,

title = "癌症放射治療的增敏劑",

abstract = "本發明關於白血病抑制因子抑制劑的用途，此用途為用於製備癌症放射治療的增敏劑。本發明亦關於白血病抑制因子接受器抑制劑的用途，此用途為用於製備癌症放射治療的增敏劑。",

author = "Yu-Sun Chang and Ngan-Ming Tsang and SHUCHEN LIU",

note = "A61K 45/08(2006.01); A61P 35/00(2006.01)",

year = "2015",

month = may,

day = "16",

language = "繁體中文",

type = "Patent",

}

TY - PAT

T1 - 癌症放射治療的增敏劑

AU - Chang, Yu-Sun

AU - Tsang, Ngan-Ming

AU - LIU, SHUCHEN

N1 - 公開公告號: 2.01517918E8 Announcement ID: 2.01517918E8

PY - 2015/5/16

Y1 - 2015/5/16

N2 - 本發明關於白血病抑制因子抑制劑的用途，此用途為用於製備癌症放射治療的增敏劑。本發明亦關於白血病抑制因子接受器抑制劑的用途，此用途為用於製備癌症放射治療的增敏劑。

AB - 本發明關於白血病抑制因子抑制劑的用途，此用途為用於製備癌症放射治療的增敏劑。本發明亦關於白血病抑制因子接受器抑制劑的用途，此用途為用於製備癌症放射治療的增敏劑。

M3 - 專利

ER -

癌症放射治療的增敏劑

Abstract

Bibliographical note

UN SDGs

Fingerprint

Cite this